The laboratories also offer highly sensitive NGS - based MRD assays to track FLT3 mutations and patient - specific immunoglobulin and T -
cell receptor gene rearrangements.
The antigen receptor genes that undergo rearrangements are the immunoglobulin heavy chain (IGH) and light chain loci (IGK and IGL) in B cells, and the T
cell receptor gene loci (TRA, TRB, TRG and TRD) in T cells.
This receptor is made using one of two duplicated copies of the T -
cell receptor gene, called C1 or C2, at random.
Steven A. Rosenberg and colleagues show that bulk T cells transduced with T
cell receptor genes are used to treat patients with melanoma, bypassing the need to expand tumor - specific T cells from patients with cancer.
Antiviral NK cell responses in HIV infection: I. NK
cell receptor genes as determinants of HIV resistance and progression to AIDS.
Invivoscribe products identify clonal rearrangements within the immunoglobulin and T -
cell receptor genes, which helps identify clonal B - and T - cell populations.
Not exact matches
US - based pharmaceutical company Gilead Sciences entered the chimeric antigen
receptor (CAR) T -
cell therapy business through its acquisition of Kite Pharma, and Australian biopharma company CSL Behring acquired US - based Calimmune, a company that develops clinical - stage
gene therapy solutions.
Researchers in England have found that in trace amounts, they activate estrogen
receptors in
cells, which in turn alters the activity of certain
genes.
In particular, the PTPRF
gene, which is known to suppress intracellular signals that are usually triggered by insulin binding to its
receptor on the
cell surface, may serve as a biomarker linking insulin resistance with insufficient milk supply.
When similar analysis was performed on the db mice, it was found that the disrupted db
gene was responsible for encoding a protein that functions as a leptin
receptor: When it binds circulating leptin at the
cell surface, it sets in motion a biochemical cascade inside the
cell.
The protein expressed by the
gene is thought to bind to serotonin
receptor molecules and ferry them to the
cell surface, positioning them to receive serotonin's signals from neighboring
cells.
Since
genes for the T -
cell receptor beta chain were previously shown to be on mouse chromosome 6, all three of the Ig - like multigene families expressed and rearranged in T
cells are located on different chromosomes, just as are the B -
cell multigene families for the Ig heavy chain, and the Ig kappa and lambda light chains.
«Fibroblast growth factor
receptor inhibitors are new therapies being developed in clinical trials for patients whose cancer
cells have genetic alterations in this family of
genes,» says Roychowdhury, a member of the OSUCCC — James Translational Therapeutics Program.
One key
gene encodes the making of a
receptor called TREM2, a docking site for molecules on the surface of microglia and other innate immune
cells.
This is how progesterone boosts CK5 +
cells — like tiny gatekeepers, progesterone
receptors and their cofactors sit in front of the
gene CK5, opening the doors of DNA to be read at this point.
In the new work, Evans» group focused on estrogen - related
receptor gamma (ERRγ), a
gene that is active at high levels in brown fat
cells.
The mutation, in a
gene called HTR2B, prevents production of the serotonin 2B
receptor, a key docking point in brain
cells for the neurotransmitter serotonin.
Although the men with the mutant
genes produced FSH, support
cells for the sperm - producing
cells in their testes lacked the
receptors for the hormone.
The most common, found in nearly two - thirds of the samples, were abnormalities in
genes responsible for the androgen
receptor — a
cell structure that sends growth signals in response to the male hormone androgen.
The control mice, with all
genes intact, should have lost sight as photo -
receptors — the light - sensitive
cells in the retina — died.
Zwiebel and colleagues scanned the mosquito genome looking for
genes similar to those that generate fruit fly odorant
receptors, proteins that project from nerve
cells and initiate a biochemical cascade when they encounter certain molecules in the air.
The researchers scoured the already deciphered mouse genome, looking for
genes that might encode additional
receptor proteins in its olfactory system, the sensory
cells that connect the nose to the brain.
In the case of SISSA's Neurobiology Laboratory, the focus was on the
genes of olfactory
receptors which, surprisingly, are also present in the
cells that synthesise dopamine and that die in Parkinson's disease.
The former target, say, using
gene editing techniques to inactivate HIV
receptors and achieve resistance of blood
cells to the virus (which Sangamo BioSciences is working on in clincial trials) is different than helping parents who both carry
genes for Huntington's Disease to have a child that is free of the disease (a change to the genome that would be passed on to future generations and would likely not be very commonly needed).
Researchers indeed now know fine details about the
genes,
receptors, and
cell - to -
cell communications that drive these processes.
They discovered that those with the disorder had mutations on a specific
gene, called GPR54, which is known to produce a
receptor in
cell membranes.
The IFNGR
receptor is one of these membrane proteins and undertakes to activate
genes involved in a huge variety of
cell processes, including defence against pathogens and cancer.
When a methyl group is attached to a
gene, it keeps that
gene hidden from
cells» protein - building machinery — in this case, preventing the
cells from manufacturing GABA - A
receptors.
The Pm3
gene is the «blueprint» for a protein that can receive signals in the plant
cell, i.e. a
receptor.
These
receptors, called
receptor tyrosine kinases (RTKs), transmit instructions through the
cell wall and down through a cascade of reactions to a target
gene in the nucleus.
Multiplexed genetic screening for epidermal growth factor
receptor (EGFR) and anaplastic lymphoma kinase (ALK)
gene rearrangements and subsequent biomarker - guided treatment is cost - effective compared with standard chemotherapy treatment without any molecular testing in the metastatic non-small
cell lung cancer (NSCLC) setting in the United States.
June's team also wants to knock out two
gene segments that encode different portions of the protein that makes up a T
cell's primary
receptor so that the engineered NS - ESO - 1
receptor will be more effective.
Among patients with advanced non-small
cell lung cancer without a mutation of a certain
gene (EGFR), conventional chemotherapy, compared with treatment using epidermal growth factor
receptor tyrosine kinase inhibitors, was associated with improvement in survival without progression of the cancer, but not with overall survival, according to a study in the April 9 issue of JAMA.
Using in vitro, or test tube, experiments, the researchers applied these chemicals to human cancer
cells to measure changes of estrogen
receptor - and androgen
receptor - target
genes and transcriptional activity.
Under normal circumstances, people whose taste
receptor cells make more messenger RNA (mRNA) for a given
gene make more of the encoded
receptor.
They injected a mutant
gene for a
cell - surface
receptor for bmp into the right legs of two - day - old chicken embryos.
Epidermal growth factor
receptor (EGFR) tyrosine kinase inhibitors (TKIs) are the preferred treatment option for patients with advanced non-small
cell lung cancer (NSCLC) who have mutations in the EGFR
gene.
Most resistance
genes, in wheat and other plants, code for protein
receptors located inside
cells; the Stb6
gene codes for a
receptor protein on the
cell's surface.
Specifically, the bipolar neurons expressed more
genes for membrane
receptors and ion channels than non-bipolar
cells, particularly those
receptors and channels involved in the sending and receiving of calcium signals between
cells.
Now, findings from Monell reveal that a person's sensitivity to bitter taste is shaped not only by which taste
genes that person has, but also by how much messenger RNA — the
gene's instruction guide that tells a taste
cell to build a specific
receptor — their
cells make.
By injecting the
gene for the vasopressin
receptor into the ventral pallidum of promiscuous voles, researchers were able to make the
cells in that area produce levels of the
receptor comparable to those of monogamous species.
The
gene, Igf2r, directs the body's
cells to produce IGF - 2
receptors that stick to the protein and prevent it from circulating and promoting growth.
Akassoglou and her colleagues thought they had a good candidate in the
gene for the p75 neurotrophin
receptor (p75NTR), a regulator of
cell death in the brain that also switches on soon after liver injuries.
Through
gene therapy, researchers engineered blood - forming stem
cells (hematopoietic stem / progenitor
cells, or HSPCs) to carry chimeric antigen
receptor (CAR)
genes to make
cells that can detect and destroy HIV - infected
cells.
According to the 6 April report in the Journal of Assisted Reproduction and Genetics, researchers at Guangzhou Medical University in China attempted — with limited success — to modify the CCR5
gene, which codes for a
cell receptor that the HIV virus uses to enter T
cells.
Without it, NFAT initiates a negative regulatory program that activates
genes encoding inhibitory
cell surfaces markers and blunts signals received by the T
cell receptor.
By activating the Ret
receptor, the scientists were able to prevent in flies and human
cell cultures the degeneration of mitochondria, which is caused by a
gene defect related to Parkinson's disease.
But only after engaging the target and adjusting their antigen
receptors over many generations (as B
cells do by mutating their antigen
receptor genes) can this lineage of
cells produce VRC26 bnAbs.
The
gene codes for an immune
receptor on red blood
cells; lack of that
receptor prevents infection by Plasmodium vivax, a species of the malaria parasite.
To do this, they incorporated the
gene sequence of each
receptor into cultured
cells and then probed the
cells to determine if they were activated by one or more of 25 different bitter - tasting chemicals.